ACCOUNTS - Final Accounts


Caseware UK (AP4) 2020.0.247 2020.0.247 2019-11-01false72110 - Research and experimental development on biotechnology77truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 04926092 2019-11-01 2020-10-31 04926092 2020-10-31 04926092 2018-11-01 2019-10-31 04926092 2019-10-31 04926092 c:Director1 2019-11-01 2020-10-31 04926092 d:CurrentFinancialInstruments 2020-10-31 04926092 d:CurrentFinancialInstruments 2019-10-31 04926092 d:CurrentFinancialInstruments d:WithinOneYear 2020-10-31 04926092 d:CurrentFinancialInstruments d:WithinOneYear 2019-10-31 04926092 d:ShareCapital 2020-10-31 04926092 d:ShareCapital 2019-10-31 04926092 d:SharePremium 2020-10-31 04926092 d:SharePremium 2019-10-31 04926092 d:RetainedEarningsAccumulatedLosses 2020-10-31 04926092 d:RetainedEarningsAccumulatedLosses 2019-10-31 04926092 c:FRS102 2019-11-01 2020-10-31 04926092 c:AuditExempt-NoAccountantsReport 2019-11-01 2020-10-31 04926092 c:FullAccounts 2019-11-01 2020-10-31 04926092 c:PrivateLimitedCompanyLtd 2019-11-01 2020-10-31 04926092 2 2019-11-01 2020-10-31 04926092 4 2019-11-01 2020-10-31 04926092 6 2019-11-01 2020-10-31 iso4217:GBP xbrli:pure
Registered number: 04926092


OMNICYTE LIMITED








UNAUDITED

PAGES FOR FILING WITH REGISTRAR

FOR THE PERIOD ENDED 31 October 2020

 
OMNICYTE LIMITED
Registered number: 04926092

BALANCE SHEET
As at 31 October 2020

2020
2019
Note
£
£

Fixed assets
  

Investments
 3 
49
143

  
49
143

Current assets
  

Debtors: amounts falling due within one year
 4 
125,102
125,104

Cash at bank and in hand
 5 
501
525

  
125,603
125,629

Creditors: amounts falling due within one year
 6 
(76,970)
(74,010)

Net current assets
  
 
 
48,633
 
 
51,619

Total assets less current liabilities
  
48,682
51,762

  

Net assets
  
48,682
51,762


Capital and reserves
  

Called up share capital 
  
106
106

Share premium account
  
199,996
199,996

Profit and loss account
  
(151,420)
(148,340)

  
48,682
51,762


Page 1

 
OMNICYTE LIMITED
Registered number: 04926092
    
BALANCE SHEET (CONTINUED)
As at 31 October 2020

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Professor N Habib
Director

Date: 13 August 2021

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
OMNICYTE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
For the Year Ended 31 October 2020

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
1.2

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
1.3

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

 
1.4

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each Balance Sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
1.5

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
1.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
1.7

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
1.8

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other
Page 3

 
OMNICYTE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
For the Year Ended 31 October 2020

1.Accounting policies (continued)


1.8
Financial instruments (continued)

third parties, loans to related parties and investments in ordinary shares.


2.


Employees

The average monthly number of employees, including directors, during the year was 7 (2019 - 7).


3.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 November 2019
143


Disposals
(94)



At 31 October 2020
49





4.


Debtors

2020
2019
£
£


Other debtors
125,102
125,104

125,102
125,104



5.


Cash and cash equivalents

2020
2019
£
£

Cash at bank and in hand
501
525

501
525


Page 4

 
OMNICYTE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
For the Year Ended 31 October 2020

6.


Creditors: Amounts falling due within one year

2020
2019
£
£

Trade creditors
1,440
-

Amounts owed to group undertakings
57,320
57,320

Other creditors
16,770
15,250

Accruals and deferred income
1,440
1,440

76,970
74,010


 
Page 5